|Bid||0.00 x 3000|
|Ask||0.00 x 3100|
|Day's Range||62.16 - 62.88|
|52 Week Range||57.17 - 74.12|
|Beta (5Y Monthly)||0.38|
|PE Ratio (TTM)||17.52|
|Earnings Date||Jul 27, 2022 - Aug 01, 2022|
|Forward Dividend & Yield||2.92 (4.68%)|
|Ex-Dividend Date||Jun 14, 2022|
|1y Target Est||69.21|
Subscribe to Yahoo Finance Plus to view Fair Value for GILD
Expectations are low for this earnings season. Will companies surprise the Street?
Gilead Sciences (GILD) closed the most recent trading day at $62.34, moving -0.03% from the previous trading session.
Biotech giant Gilead Sciences (NASDAQ: GILD) has a lot going its way, including the company's juicy dividend yield of 4.7%. With this backdrop in mind, let's consider whether Gilead Sciences' dividend is safe. Gilead Sciences has been highly successful in the market for COVID-19 therapies thanks to its antiviral Veklury.